Skip to Content

Grapefruit USA Inc GPFT

Morningstar Rating
$0.00 0.00 (5.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GPFT is trading at a 40% discount.
Price
$0.00
Fair Value
$6.54
Uncertainty
Extreme
1-Star Price
$5.77
5-Star Price
$8.34
Economic Moat
Pyxvd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GPFT is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.00
Market Cap
$681,532.08
Volume/Avg
26,511 / 641,988

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Grapefruit USA Inc manufactures and distributes cannabis-based products. Its extraction lab produces high-quality distillate or Honey Oil from trim that Grapefruit sources through its Distribution arm. The company is a premier licensed Distributor of all things cannabis throughout the State of California. It serves licensed Medicinal and Recreational Dispensaries. Its patented product is Hourglass Cream. Grapefruit owns and operates a California-licensed cannabis extraction laboratory and wholesale distribution facility in the Coachillin' Canna-Business Park near Palm Springs, California.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
9

Valuation

Metric
GPFT
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
GPFT

Financial Strength

Metric
GPFT
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
−1.78
Quick Ratio
GPFT

Profitability

Metric
GPFT
Return on Assets (Normalized)
−138.29%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
GPFT
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AMbj$90.2 Bil
MKKGY
Merck KGaA ADRCwgcqk$73.5 Bil
HLN
Haleon PLC ADRNfy$37.9 Bil
VTRS
Viatris IncMlnbc$16.1 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRYxbm$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRGbht$12.9 Bil
CTLT
Catalent IncYfzlr$10.5 Bil
PRGO
Perrigo Co PLCLbs$4.4 Bil
CURLF
Curaleaf Holdings IncJvtk$3.8 Bil
PBH
Prestige Consumer Healthcare IncGpnysv$3.5 Bil

Sponsor Center